-
AO/PI Double Staining Kit: Precision Assay Design for Apopto
2026-05-21
Explore the AO/PI Double Staining Kit as a robust tool for apoptosis and necrosis detection. This article delivers an in-depth, assay-focused perspective on Acridine Orange Propidium Iodide staining, grounded in the latest scientific advances.
-
PDHA1 Acetylation and Cuproptosis Resistance in Prostate Can
2026-05-21
This study uncovers the role of PDHA1 acetylation in suppressing cuproptosis, contributing to resistance against anti-androgen therapy in castration-resistant prostate cancer. The findings highlight a metabolic-epigenetic axis as a therapeutic target to restore drug sensitivity and promote regulated cell death in aggressive prostate tumors.
-
Resiniferatoxin (RTX): Precision Tool for TRPV1 Pain Researc
2026-05-20
Resiniferatoxin (RTX) delivers unparalleled selectivity and potency for the chemical inactivation of TRPV1-positive sensory neurons, enabling advanced modeling of pain and neurogenic inflammation. Explore refined protocols, troubleshooting insights, and new evidence on RTX’s role in mechanistic assays and disease models.
-
Cy5-UTP: Transforming RNA Labeling for Multicolor FISH & Arr
2026-05-20
Harness the power of Cy5-UTP (Cyanine 5-UTP) for high-sensitivity, direct RNA labeling in advanced molecular biology. Discover how its workflow compatibility, robust fluorescence, and unique protocol optimizations streamline in vitro transcription and empower next-generation FISH and dual-color expression array applications.
-
Deferoxamine mesylate (SKU B6068): Reliable Iron Chelation f
2026-05-19
This article delivers scenario-driven guidance on deploying Deferoxamine mesylate (SKU B6068) in cell viability, proliferation, and cytotoxicity workflows. Drawing from published data and practical experience, it addresses assay reproducibility, protocol optimization, and vendor reliability, helping biomedical researchers ensure consistent, high-quality results.
-
Cyclosporin A: Bridging Mechanism and Translation in Immunol
2026-05-19
A thought-leadership article for translational researchers, illuminating the mechanistic landscape of Cyclosporin A (cyclosporine) as a cyclophilin inhibitor, and providing strategic, evidence-backed guidance for its deployment across autoimmune disorder research, apoptosis modulation, and viral entry inhibition. Building on foundational protocol literature and highlighting new intersections with drug delivery innovation, the piece positions APExBIO’s Cyclosporin A for next-generation translational impact.
-
Gepotidacin (GSK2140944): Benchmarks and Protocols for Antib
2026-05-18
Gepotidacin is a first-in-class bacterial type II topoisomerase inhibitor with unique efficacy against multidrug-resistant pathogens. This article details its molecular mechanism, in vitro/in vivo benchmarks, and protocol parameters for advanced antibacterial research.
-
Annexin V-Cy5/DAPI Apoptosis Kit: High-Fidelity Cell Death D
2026-05-18
The Annexin V-Cy5/DAPI Apoptosis Kit enables rapid, dual-marker detection of apoptosis and necrosis with high sensitivity. This apoptosis detection kit leverages phosphatidylserine binding and DAPI staining to differentiate cell death stages, facilitating robust, reproducible results in cell biology research.
-
Tigecycline in Experimental MDR Models: Protocols and Innova
2026-05-17
Tigecycline, a pioneering glycylcycline antibiotic, offers unmatched versatility in the experimental modeling of multidrug-resistant (MDR) pathogens. Discover how optimized protocols and insights from recent transmission studies can supercharge your antimicrobial research and troubleshooting.
-
ARCA EGFP mRNA (5-moUTP): Benchmarking Immunogenicity & Stab
2026-05-16
Explore how ARCA EGFP mRNA (5-moUTP) redefines polyadenylated mRNA transfection with advanced immunogenicity suppression and stability enhancement. This article delivers new comparative insights and protocol clarity for fluorescence-based assays.
-
TMEM16F Lipid Scrambling Modulates Ferroptosis and Tumor Imm
2026-05-15
Yang et al. (2025) demonstrate that TMEM16F-mediated lipid scrambling suppresses ferroptosis at the plasma membrane by redistributing phospholipids during oxidative stress, thereby protecting cells from membrane rupture. Disruption of this process sensitizes cells to ferroptosis and enhances anti-tumor immune responses, opening new avenues for therapeutic intervention in cancer.
-
Gap26 Connexin 43 Mimetic Peptide: Mitochondrial Transfer an
2026-05-15
Explore how Gap26, a leading connexin 43 mimetic peptide, enables precision control of mitochondrial transfer in ischemia-reperfusion injury models. This article delivers a deep dive into Gap26's mechanism, protocol nuances, and its unique value for hepatic and vascular research.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis: Insig
2026-05-14
This study identifies moesin (MSN) as a novel, quantifiable biomarker of endothelial injury severity in sepsis, linking serum MSN levels to clinical outcomes and mechanistic endothelial dysfunction. The work provides a foundation for biomarker-guided sepsis evaluation and highlights experimental strategies relevant for vascular biology research.
-
High-Throughput In Vitro BBB Permeability: LLC-PK1-MOCK/MDR1
2026-05-14
Hu et al. (2025) introduce a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and MDR1 cells, with lysosomal trapping correction, to predict CNS drug permeability. This approach streamlines early-stage neurological drug screening and offers improved accuracy over traditional methods.
-
KN-62: Selective CaMKII Inhibition for Precise Calcium Studi
2026-05-13
KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine is a potent and selective CaMKII inhibitor. It enables rigorous dissection of calcium signaling, insulin secretion, and cell cycle regulation in research models. APExBIO's KN-62 provides reproducible results for advanced biochemical and cellular studies.